Human medicines European public assessment report (EPAR): Zokinvy, lonafarnib, Date of authorisation: 18/07/2022, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Stalevo, levodopa,carbidopa,entacapone, Date of authorisation: 17/10/2003, Revision: 30, Status: Authorised
Work plan for the Committee for Veterinary Medicinal Products (CVMP) Efficacy Working Party (EWP-V) 2025
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 9-12 December 2024
List of medicines currently in PRIME scheme
Checklist for annual updates for parallel distribution: guidance for industry
Checklist for initial notifications for parallel distribution: guidance for industry
Certification of medicinal products
Information package for certificates of medicinal products issued by the European Medicines Agency
We are delighted to announce that applications for the EFIM Exchange Programme 2025 are now open!